Filing Flows › Emergent BioSolutions (EBS) › Operating margin
Emergent BioSolutions (EBS) operating margin by quarter
Emergent BioSolutions' operating margin was 6.7% in Q1 2026 (first quarter 2026), -26.4 pts from Q3 2025. Over the last 3 quarters it ranged from 6.7% (Q1 2026) to 33.1% (Q3 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q1 2026 | 6.7% | -26.4 pts | -15.7 pts |
| Q3 2025 | 33.1% | +10.6 pts | — |
| Q1 2025 | 22.5% | — | — |
Q1 2026 at a glance
Emergent BioSolutions, Q1 2026: revenue $156M (-30% year over year), operating margin 6.7%, net earnings $6.8M, operating cash flow −$33.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Emergent BioSolutions' operating margin?
Emergent BioSolutions' operating margin was 6.7% in Q1 2026 (first quarter 2026), -26.4 pts from Q3 2025.
How has Emergent BioSolutions' operating margin changed?
Over the last 3 quarters it ranged from 6.7% (Q1 2026) to 33.1% (Q3 2025).